While potential vaccines for COVID-19 are being developed, there is a very real issue that we all need to be aware of. It is predicted that 10% of pharma products worldwide are counterfeit. Alf Goebel at advanco analyses how pharmaceutical serialisation providers can step up the fight against drug counterfeiting by adopting a more open and agile supply chain.